Suspected Immune Thrombocytopenic Purpura Induced by Lenalidomide for the Treatment of Myelodysplastic Syndrome with Deletion of Chromosome 5q: A Case Report

Lenalidomide (LEN), one of the key drugs in the treatment of myelodysplastic syndromes (MDS) with 5q deletion, as well as multiple myeloma (MM), has various immunomodulatory effects and has been associated with autoimmune diseases, including immune thrombocytopenic purpura (ITP). A 78-year-old man p...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	The Tohoku Journal of Experimental Medicine 2023, Vol.259(2), pp.113-119
Hauptverfasser:	Furukawa, Haruna, Nomura, Jun, Kobayashi, Masahiro, Abe, Shori, Takeda, Tomoki, Oka, Yumiko, Shirota, Yuko, Kodera, Takao, Okitsu, Yoko, Takahashi, Shinichiro, Murakami, Keigo, Kameoka, Junichi
Format:	Artikel
Sprache:	eng
Schlagworte:	5q− syndrome Aged Chromosomes Humans immune thrombocytopenic purpura lenalidomide Lenalidomide - therapeutic use Male Multiple Myeloma myelodysplastic syndrome Myelodysplastic Syndromes - complications Myelodysplastic Syndromes - drug therapy Purpura, Thrombocytopenic, Idiopathic - drug therapy Thrombocytopenia
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!